«MODIFIED-RELEASE»に関連する英語の本
以下の図書目録から
modified-releaseの使いかたを見つけましょう。
modified-releaseに関する本と英語文献で使われた文脈を提供するための簡単な抜粋文。
1
Modified-
Release Drug Delivery Technology
Describing formulation challenges and their solutions in the design, development, and commercialization of modified-release drugs delivery systems, this book contains eighty papers that review recent developments in design and manufacturing ...
Michael J. Rathbone, Jonathan Hadgraft, Michael S. Roberts, 2002
2
Developing Solid Oral Dosage Forms: Pharmaceutical Theory & ...
20.1. Introduction. Modified release (MR) drug delivery systems are developed to
modulate the apparent absorption and/ or alter the site of release of drugs, in
order to achieve specific clinical objectives that cannot be attained with ...
Yihong Qiu, Yisheng Chen, Geoff G.Z. Zhang, 2009
3
Oral Controlled
Release Formulation Design and Drug ...
In designing such modified release oral drug delivery systems, pharmaceutical
excipients play an important role. Among the pharmaceutical excipients,
polymers are extensively used for developing various modified release
pharmaceutical ...
Hong Wen, Kinam Park, 2011
4
Handbook of Drug-Nutrient Interactions
Systemic availability of a drug from the modified-release product under fed
conditions is complex. It consists of a combination of the physiological effects of
meals on drug release (affecting disintegration, dissolution, degradation, or
diffusion) ...
Joseph I. Boullata, Vincent T. Armenti, 2010
5
Clinical Trials in Rheumatology
CAPRA-Trial Efficacy of modified-release versus standard prednisone to reduce
duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a
double-blind, randomised controlled trial CAPRA: Circadian Administration of ...
Ruediger Mueller, Johannes von Kempis, 2010
6
Introduction to Pharmacokinetics and Pharmacodynamics: The ...
Other products, modified-release dosage forms, have been developed to release
drug at a controlled rate. The purpose here is generally either to avoid contact
with gastric fluids (acidic environment) or to prolong drug input into the systemic ...
Thomas N. Tozer, Malcolm Rowland, 2006
7
Design, Preparation and Characterization of
Modified Release ...
The objective of this study was to test two hypotheses to achieve tailored drug release from single unit (tablet) and multiple units (beads) drug delivery systems.
8
Controlled
Release in Oral Drug Delivery
These various approaches, although of different levels of complexity, offer the
hope of greater accuracy in the prediction of the human pharmacokinetics for oral
modified release dosage forms, and a much improved opportunity to
prospectively ...
Clive G. Wilson, Patrick J. Crowley, 2011
9
Modified-
Release Drug Delivery Technology, Second Edition ...
This two volume "Second Edition" describes the anatomical, physiological, pharmaceutical, and technological aspects of oral, colonic and rectal, ocular, oral mucosal, dermal and transdermal, nasal, vaginal, and pulmonary delivery routes, ...
Michael J Rathbone, Jonathan Hadgraft, D.Phil., D.SC., Michael S Roberts, 2008
10
Nimesulide - Actions and Uses
Site* capsule with drug release in the proximal small-bowel (B), in the distal small
bowel (C) or in the ascending colon (D) cessful development of a modified
release formulation is that the drug is absorbed throughout the whole intestine, ...
用語«MODIFIED-RELEASE»を含むニュース項目
国内外の報道機関が語った内容や、次のニュース項目の文脈から
modified-releaseという用語がどのように使われているかを調べてみましょう。
IPO Report: Neos Therapeutics (NEOS)
NEOS's proprietary modified-release drug delivery platform has enabled NEOS to create novel, extended-release ODT and liquid suspension ... «Equities.com, 7月 15»
Four New IPOs for the Week of July 20
... pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug ... «Equities.com, 7月 15»
Neos Therapeutics (NEOS) Announces July 23rd IPO
... on developing, manufacturing and commercializing products utilizing our proprietary modified-release drug delivery technology platform, ... «The Legacy, 7月 15»
Neos Therapeutics Upcoming IPO: What Investors Need to Know
... on developing, manufacturing and commercializing products utilizing their proprietary modified-release drug delivery technology platform. «Profit Confidential, 7月 15»
Pfizer once-daily arthritis tablets reach FDA review
Drugs giant Pfizer has indicated it has lodged a new drug application for a once-daily modified-release 11 mg tofacitinib citrate tablet. «Digital Journal, 7月 15»
Neos Therapeutics Sets Price for IPO
Our proprietary modified-release drug delivery platform has enabled us to create novel, extended-release ODT and liquid suspension dosage ... «24/7 Wall St., 7月 15»
FDA to review modified-release version of Pfizer's Xeljanz for …
Pfizer just announced that the FDA agreed to review a daily, 11-milligram modified-release tablet of its rheumatoid arthritis drug Xeljanz for ... «FierceDrugDelivery, 7月 15»
Clinical trial underway for microbiome-based therapy for IBS-C
SYN-010 is a modified-release formulation of lovastatin intended to reduce the methane production of the gut microbe M. smithii while ... «Healio, 6月 15»
Synthetic Biologics Initiates Phase 2 Clinical Trial to Treat Irritable …
SYN-010 is a proprietary, modified-release formulation of the classic statin, lovastatin, that is intended to reduce methane production by certain ... «EndoNurse, 6月 15»
Neos Therapeutics Presents Data On ADHD Therapy At ASCP …
We are also encouraged to see that the modified-release properties of NT-0202 are maintained in the presence of alcohol. We believe that this ... «BioNews Texas, 6月 15»
